ALPS Advisors’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.77M | Sell |
26,532
-5,832
| -18% | -$609K | 0.02% | 322 |
|
|
2025
Q1 | $3.77M | Sell |
32,364
-6,826
| -17% | -$796K | 0.02% | 267 |
|
|
2024
Q4 | $3.32M | Buy |
+39,190
| New | +$3.32M | 0.02% | 275 |
|
|
2024
Q2 | – | Sell |
-33,417
| Closed | -$2.67M | – | 970 |
|
|
2024
Q1 | $2.67M | Buy |
33,417
+935
| +3% | +$74.6K | 0.02% | 308 |
|
|
2023
Q4 | $2.59M | Sell |
32,482
-2,346
| -7% | -$187K | 0.02% | 303 |
|
|
2023
Q3 | $2.43M | Buy |
34,828
+2,800
| +9% | +$196K | 0.02% | 294 |
|
|
2023
Q2 | $2.3M | Buy |
32,028
+3,353
| +12% | +$241K | 0.02% | 286 |
|
|
2023
Q1 | $1.77M | Sell |
28,675
-748
| -3% | -$46.1K | 0.02% | 313 |
|
|
2022
Q4 | $2.27M | Buy |
+29,423
| New | +$2.27M | 0.02% | 279 |
|